Ana I. Stancic

2011

In 2011, Ana I. Stancic earned a total compensation of $1.2M as Former Principal Executive Officer, Executive Vice President, Chief Operating Officer and Chief Financial Officer at Enzon Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$117,000
Option Awards$376,914
Salary$201,462
Stock Awards$542,150
Other$6,044
Total$1,243,569

Stancic received $542.2K in stock awards, accounting for 44% of the total pay in 2011.

Stancic also received $117K in non-equity incentive plan, $376.9K in option awards, $201.5K in salary and $6K in other compensation.

Rankings

In 2011, Ana I. Stancic's compensation ranked 4,872nd out of 10,747 executives tracked by ExecPay. In other words, Stancic earned more than 54.7% of executives.

ClassificationRankingPercentile
All
4,872
out of 10,747
55th
Division
Manufacturing
1,749
out of 3,960
56th
Major group
Chemicals And Allied Products
366
out of 1,033
65th
Industry group
Drugs
222
out of 781
72nd
Industry
Biological Products, Except Diagnostic Substances
36
out of 157
77th
Source: SEC filing on October 11, 2013.

Stancic's colleagues

We found three more compensation records of executives who worked with Ana I. Stancic at Enzon Pharmaceuticals in 2011.

2011

Andrew Rackear

Enzon Pharmaceuticals

General Counsel

2011

Aby Buchbinder

Enzon Pharmaceuticals

Former Vice President, Clinical Development

2011

Timothy Daly

Enzon Pharmaceuticals

Chief Accounting Officer

You may also like